• TEL: 0086-13083697781

adaptimmune therapeutics plc adap

Get Price

We can supply you need adaptimmune therapeutics plc adap.

ADAP - Adaptimmune Therapeutics PLC Summary, Stock

Adaptimmune Therapeutics PLC (NYSE:ADAP) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and ADAP - Adaptimmune Therapeutics plc BioPharmCatalystPHILADELPHIA and OXFORDSHIRE, United Kingdom, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in cell therapy to treat cancer, will host a virtual Investor Day today, which will feature the Company's Senior Leadership team and Dr Dejka Araujo of the MD Anderson Cancer Center.

ADAP / Adaptimmune Therapeutics plc - Institutional

Adaptimmune Therapeutics PLC (ADAP) Upgraded to Strong Buy:Here's Why. 2019-07-09 zacks - 7 - Investors might want to bet on Adaptimmune Therapeutics PLC (ADAP - Free Report) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates - one of the most ADAP Adaptimmune Therapeutics plc Stock QuoteAdaptimmune Therapeutics plc (ADAP) Shares March Higher, Can It Continue? Zacks. Jan-24-20 04:30PM :Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares. GlobeNewswire. Jan-22-20 01:18PM :Philadelphia cell therapy company prices $84M public stock offering. ADAP Stock Price Adaptimmune Therapeutics PLC ADR Dec 09, 2020 · Adaptimmune Therapeutics plc (ADAP) Shares March Higher, Can It Continue? Feb. 3, 2020 at 9:13 a.m. ET on Zacks. Top Ranked Momentum Stocks to

Active Condition Now? Adaptimmune Therapeutics plc (ADAP

2 days ago · Adaptimmune Therapeutics plc (ADAP) traded 4992682 shares on hands in most recent trading session and observed an average volume with 1483.57K shares. The stock acknowledged active focus on shares in the current trading session. ADAP disclosed a change of -1.23% and its listed share value at $4 in the recent trade transaction. Active Condition Now? Adaptimmune Therapeutics plc (ADAP 2 days ago · Adaptimmune Therapeutics plc (ADAP) traded 4992682 shares on hands in most recent trading session and observed an average volume with 1483.57K shares. The stock acknowledged active focus on shares in the current trading session. ADAP disclosed a change of -1.23% and its listed share value at $4 in the recent trade transaction. Adaptimmune Therapeutics (NASDAQ:ADAP) Shareholders Dec 11, 2020 · Some Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders are probably rather concerned to see the share price fall 49% over the last three months.On the other hand, over the last twelve months the stock has delivered rather impressive returns. Indeed, the share price is up an impressive 227% in that time.

Adaptimmune Therapeutics plc (ADAP) Just Got Our

Dec 09, 2020 · Adaptimmune Therapeutics plc (NASDAQ:ADAP) went down by -2.22% from its latest closing price compared to the recent 1-year high of $13.40. The companys stock price has collected -7.37% of loss in the last five trading sessions. Press Release reported on 11/20/20 that Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Adaptimmune Therapeutics plc (ADAP) Options Chain - Yahoo Adaptimmune Therapeutics plc (ADAP) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. Visitors trend 2W 10W 9M. 4.5050 +0.0350 (+0.78%) As of 3:53PM EST. Market open. Adaptimmune Therapeutics plc (ADAP) Stock Price, News Find the latest Adaptimmune Therapeutics plc (ADAP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Adaptimmune Therapeutics plc [ADAP] stock Initiated by

2 days ago · Adaptimmune Therapeutics plc [NASDAQ:ADAP] closed the trading session at $4.00 on 12/11/20. The days price range saw the stock hit a low of $3.79, while the highest price level was $4.11. The company report on November 20, 2020 that Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Market cap of Adaptimmune Therapeutics plc [ADAP] Nov 23, 2020 · Adaptimmune Therapeutics plc [NASDAQ:ADAP] gained 5.30% on the last trading session, reaching $4.97 price per share at the time. The company report on November 20, 2020 that Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day.. Get the hottest stocks to trade every day before the Presentations ::Adaptimmune Therapeutics plc (ADAP)2016 Adaptimmune Analyst and Investor Day . Mar 7, 2016. ADAP Presentation March 2016

Short term estimates and forecasts for Adaptimmune

2 days ago · Adaptimmune Therapeutics plc (NASDAQ:ADAP) has a beta value of 2.4 and has seen 4,992,682 shares traded in the last trading session. The company, currently valued at $619.12 Million, closed the last trade at $4 per share which meant it lost -$0.05 on the day or -1.23% during that session. Adaptimmune Therapeutics plc [ADAP] stock Initiated by 2 days ago · Adaptimmune Therapeutics plc [ADAP]:An insightful look at the core fundamentals. Operating Margin for any stock indicates how profitable investing would be, and Adaptimmune Therapeutics plc [ADAP] shares currently have an operating margin of -13713.28. Adaptimmune Therapeutics plcs Net Margin is presently recorded at -12225.04.

Get Price

We can supply you need adaptimmune therapeutics plc adap.